Nathan Rice
Stock Analyst at Piper Sandler
(1.84)
# 1230
Out of 5,270 analysts
58
Total ratings
58.62%
Success rate
17.93%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Merchants Bancorp | Maintains: Overweight | 53 57 | 40.42 | 39.78% | 7 | Jan 30, 2025 | |
First Mid Bancshares | Maintains: Overweight | 46 47 | 38.08 | 23.42% | 3 | Nov 1, 2024 | |
Byline Bancorp | Reiterates: Overweight | 34 34 | 28.25 | 20.35% | 8 | Oct 29, 2024 | |
Bank First | Maintains: Neutral | 99 104 | 106.75 | -2.58% | 5 | Oct 17, 2024 | |
CVS Health | Maintains: Buy | 85 74 | 64.76 | 14.27% | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 84 | 119.98 | -29.99% | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 197 | 175.16 | 12.47% | 8 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 11 9 | 11.3 | -20.35% | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 40 | n/a | n/a | 1 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 530 435 | 436.96 | -0.45% | 4 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 233 | 311.62 | -25.23% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 83 | 58.7 | 41.4% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 15 | 18.28 | -17.94% | 1 | Dec 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 49 54 | n/a | n/a | 4 | Feb 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 31 | n/a | n/a | 2 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jul 24, 2017 |